Skip to main content
Erschienen in: Archives of Dermatological Research 10/2023

31.08.2023 | ORIGINAL PAPER

Increased d-dimer and fibrin degradation product levels as potential indicators for evaluating infection-related acute urticaria: a case-case–control study

verfasst von: Lei Zhang, Weiwei Jiang, Yacob Berhane Gebreab, Xin Ye

Erschienen in: Archives of Dermatological Research | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

About 20% of world population suffer from acute urticaria at some stage in their lives. Recent studies showed coagulation dysfunction in chronic urticaria. The involvement of coagulation changes in acute urticaria remains unclear. Fifty-eight acute urticaria patients were enrolled in this study and divided into two groups (referred to throughout as infection-related and infection-unrelated acute urticaria). The routine laboratory parameters including coagulation tests between the two groups were compared. The correlation between coagulation tests and CRP at acute phase was also assessed. Dynamic change of routine coagulation test results at acute phase and resolving phase was compared. The potential performance of coagulation for infection indication was tested. We found d-dimer, fibrin degradation product (FDP), and fibrinogen (Fg) increased in the acute phase of infection-related acute urticaria patients. d-dimer, FDP, Fg, and APTT are positively correlated with CRP in the acute phase. d-dimer and FDP decreased in the resolving phase of infection-related acute urticaria patients. Higher d-dimer (> 0.48 mg/L) and FDP (> 3.84 mg/L) may indicate infection-related acute urticaria. In conclusion, in acute urticaria with low venous thromboembolism risk, d-dimer level and dynamic change can be potentially used for the infection-related clinical practice management.
Literatur
1.
Zurück zum Zitat Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B et al (2018) The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 73:1393–1414CrossRefPubMed Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B et al (2018) The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 73:1393–1414CrossRefPubMed
2.
Zurück zum Zitat Peck G, Hashim MJ, Shaughnessy C, Muddasani S, Elsayed NA, Fleischer AB Jr (2021) Global epidemiology of urticaria: increasing burden among children, females and low-income regions. Acta Derm Venereol 101:adv00433CrossRefPubMed Peck G, Hashim MJ, Shaughnessy C, Muddasani S, Elsayed NA, Fleischer AB Jr (2021) Global epidemiology of urticaria: increasing burden among children, females and low-income regions. Acta Derm Venereol 101:adv00433CrossRefPubMed
3.
Zurück zum Zitat Cugno M, Asero R, Tedeschi A, Lazzari R, Marzano AV (2012) Inflammation and coagulation in urticaria and angioedema. Curr Vasc Pharmacol 10:653–658CrossRefPubMed Cugno M, Asero R, Tedeschi A, Lazzari R, Marzano AV (2012) Inflammation and coagulation in urticaria and angioedema. Curr Vasc Pharmacol 10:653–658CrossRefPubMed
4.
Zurück zum Zitat Sakurai M, Oba M, Matsumoto K, Tokura Y, Furukawa F, Takigawa M (2000) Acute infectious urticaria: clinical and laboratory analysis in nineteen patients. J Dermatol 27:87–93CrossRefPubMed Sakurai M, Oba M, Matsumoto K, Tokura Y, Furukawa F, Takigawa M (2000) Acute infectious urticaria: clinical and laboratory analysis in nineteen patients. J Dermatol 27:87–93CrossRefPubMed
5.
Zurück zum Zitat Takahashi T, Minami S, Teramura K, Tanaka T, Fujimoto N (2018) Four cases of acute infectious urticaria showing significant elevation of plasma D-dimer level. J Dermatol 45:1013–1016CrossRefPubMed Takahashi T, Minami S, Teramura K, Tanaka T, Fujimoto N (2018) Four cases of acute infectious urticaria showing significant elevation of plasma D-dimer level. J Dermatol 45:1013–1016CrossRefPubMed
6.
Zurück zum Zitat Hagiwara S, Oshima K, Aoki M, Murata M, Ishihara K, Kaneko M et al (2013) Usefulness of fibrin degradation products and d-dimer levels as biomarkers that reflect the severity of trauma. J Trauma Acute Care 74:1275–1278CrossRef Hagiwara S, Oshima K, Aoki M, Murata M, Ishihara K, Kaneko M et al (2013) Usefulness of fibrin degradation products and d-dimer levels as biomarkers that reflect the severity of trauma. J Trauma Acute Care 74:1275–1278CrossRef
7.
Zurück zum Zitat Ghazanfar MN, Thomsen SF (2018) D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review. Eur J Dermatol 28:731–735CrossRefPubMed Ghazanfar MN, Thomsen SF (2018) D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review. Eur J Dermatol 28:731–735CrossRefPubMed
8.
Zurück zum Zitat Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A et al (2004) Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care 8:R82-90CrossRefPubMedPubMedCentral Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A et al (2004) Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care 8:R82-90CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Dumoulin EN, Fiers L, Devreese KMJ (2016) Investigation of sensitivity for coagulation factor deficiency in APTT and PT: how to perform it? Clin Chem Lab Med 54:e169–e172CrossRef Dumoulin EN, Fiers L, Devreese KMJ (2016) Investigation of sensitivity for coagulation factor deficiency in APTT and PT: how to perform it? Clin Chem Lab Med 54:e169–e172CrossRef
11.
Zurück zum Zitat Nakae R, Murai Y, Yokobori S (2022) Biomarkers in neurological injury: fibrinogen, fibrinogen/fibrin degradation products (FDPs), and D-dimer. In: Biomarkers in trauma, injury and critical care. Springer, pp 1–15 Nakae R, Murai Y, Yokobori S (2022) Biomarkers in neurological injury: fibrinogen, fibrinogen/fibrin degradation products (FDPs), and D-dimer. In: Biomarkers in trauma, injury and critical care. Springer, pp 1–15
12.
Zurück zum Zitat Kasperska-Zajac A, Brzoza Z (2009) Increased D-dimer concentration in plasma of patients with severe acute urticaria. Br J Dermatol 161:1409–1410CrossRefPubMed Kasperska-Zajac A, Brzoza Z (2009) Increased D-dimer concentration in plasma of patients with severe acute urticaria. Br J Dermatol 161:1409–1410CrossRefPubMed
13.
Zurück zum Zitat Takahagi S, Mihara S, Iwamoto K, Morioke S, Okabe T, Kameyoshi Y et al (2010) Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy 65:649–656CrossRefPubMed Takahagi S, Mihara S, Iwamoto K, Morioke S, Okabe T, Kameyoshi Y et al (2010) Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy 65:649–656CrossRefPubMed
14.
Zurück zum Zitat Schaefer P (2017) Acute and chronic urticaria: evaluation and treatment. Am Fam Physician 95:717–724PubMed Schaefer P (2017) Acute and chronic urticaria: evaluation and treatment. Am Fam Physician 95:717–724PubMed
Metadaten
Titel
Increased d-dimer and fibrin degradation product levels as potential indicators for evaluating infection-related acute urticaria: a case-case–control study
verfasst von
Lei Zhang
Weiwei Jiang
Yacob Berhane Gebreab
Xin Ye
Publikationsdatum
31.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 10/2023
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-023-02706-2

Weitere Artikel der Ausgabe 10/2023

Archives of Dermatological Research 10/2023 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.